Dr. Sameea Sadiq, M.D
NPI: 1477747756
Total Payments
$936.01
2024 Payments
$16.89
Companies
12
Transactions
54
Medicare Patients
1,541
Medicare Billing
$169,323
Payment Breakdown by Category
Food & Beverage$822.40 (87.9%)
Education$111.84 (11.9%)
Gifts$1.77 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $822.40 | 51 | 87.9% |
| Education | $111.84 | 2 | 11.9% |
| Gift | $1.77 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Relypsa, Inc. | $296.33 | 18 | $0 (2018) |
| Mallinckrodt LLC | $290.58 | 11 | $0 (2018) |
| Keryx Biopharmaceuticals, Inc. | $97.85 | 8 | $0 (2017) |
| Amgen Inc. | $94.00 | 7 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $38.42 | 3 | $0 (2018) |
| Astute Medical, Inc. | $24.41 | 1 | $0 (2018) |
| OPKO Pharmaceuticals, LLC | $18.04 | 1 | $0 (2017) |
| Travere Therapeutics, Inc. | $16.89 | 1 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $16.81 | 1 | $0 (2017) |
| Horizon Pharma plc | $15.92 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.89 | 1 | Travere Therapeutics, Inc. ($16.89) |
| 2018 | $167.16 | 11 | Relypsa, Inc. ($49.05) |
| 2017 | $751.96 | 42 | Mallinckrodt LLC ($265.72) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/16/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 06/27/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Hyperkalemia | ||||||
| 06/27/2018 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: Nephrology | ||||||
| 06/14/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 06/06/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: NEPHROLOGY | ||||||
| 05/30/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Cardiology | ||||||
| 05/16/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 03/06/2018 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/21/2018 | Astute Medical, Inc. | Nephrocheck (Device) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Nephrology | ||||||
| 02/21/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Hyperkalemia | ||||||
| 02/13/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Cardiology | ||||||
| 01/24/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Hyperkalemia | ||||||
| 12/01/2017 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Cardiology | ||||||
| 12/01/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: Hyperkalemia | ||||||
| 11/22/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Hyperkalemia | ||||||
| 11/22/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $2.51 | General |
| Category: Hyperkalemia | ||||||
| 11/21/2017 | Keryx Biopharmaceuticals, Inc. | Auryxia (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Nephrology | ||||||
| 11/21/2017 | Keryx Biopharmaceuticals, Inc. | Auryxia (Drug) | Gift | In-kind items and services | $1.77 | General |
| Category: Nephrology | ||||||
| 11/16/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 11/02/2017 | Keryx Biopharmaceuticals, Inc. | Auryxia (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Nephrology | ||||||
| 11/01/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Hyperkalemia | ||||||
| 11/01/2017 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Cardiology | ||||||
| 10/31/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: Hyperkalemia | ||||||
| 10/26/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Hyperkalemia | ||||||
| 10/24/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 364 | 567 | $144,815 | $41,544 |
| 2022 | 8 | 292 | 503 | $133,234 | $38,151 |
| 2021 | 9 | 345 | 614 | $161,049 | $48,243 |
| 2020 | 13 | 540 | 800 | $160,274 | $41,385 |
Total Patients
1,541
Total Services
2,484
Medicare Billing
$169,323
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 268 | $77,988 | $22,338 | 28.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 41 | $16,072 | $5,003 | 31.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $12,276 | $3,373 | 27.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 50 | $9,850 | $3,006 | 30.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 33 | $9,372 | $2,894 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $10,143 | $2,624 | 25.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $7,700 | $1,846 | 24.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 24 | $264.00 | $201.60 | 76.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 39 | 46 | $782.00 | $156.40 | 20.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 44 | 46 | $368.00 | $101.20 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 284 | $82,644 | $23,712 | 28.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 38 | $14,896 | $4,833 | 32.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 53 | $10,441 | $2,844 | 27.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $10,584 | $2,682 | 25.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $7,254 | $2,018 | 27.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 24 | $6,816 | $1,897 | 27.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 44 | 46 | $368.00 | $102.19 | 27.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 12 | 21 | $231.00 | $62.25 | 26.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 138 | 328 | $95,448 | $29,645 | 31.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 43 | $16,856 | $5,107 | 30.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 38 | 38 | $16,758 | $4,547 | 27.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 37 | 68 | $13,396 | $3,798 | 28.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $7,254 | $2,245 | 30.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 20 | $5,680 | $1,605 | 28.3% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 12 | 19 | $4,902 | $1,085 | 22.1% |
About Dr. Sameea Sadiq, M.D
Dr. Sameea Sadiq, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in High Point, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1477747756.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sameea Sadiq, M.D has received a total of $936.01 in payments from pharmaceutical and medical device companies, with $16.89 received in 2024. These payments were reported across 54 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($822.40).
As a Medicare-enrolled provider, Sadiq has provided services to 1,541 Medicare beneficiaries, totaling 2,484 services with total Medicare billing of $169,323. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Nephrology
- Location High Point, NC
- Active Since 08/30/2007
- Last Updated 05/20/2013
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1477747756
Products in Payments
- Veltassa (Drug) $296.33
- ACTHAR (Biological) $290.58
- Auryxia (Drug) $97.85
- Repatha (Biological) $56.20
- Parsabiv (Biological) $37.80
- Nephrocheck (Device) $24.41
- SAMSCA (Drug) $22.95
- Rayaldee (Drug) $18.04
- Velphoro (Drug) $16.81
- KRYSTEXXA (Drug) $15.92
- ENTRESTO (Drug) $15.82
- JYNARQUE (Drug) $15.47
- ZEPATIER (Drug) $10.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in High Point
Erin Dennis, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $6,242
Student in an Organized Health Care Education/Training Program $6,242
Adetoye Lufadeju, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $1,651
Student in an Organized Health Care Education/Training Program $1,651
Molly Reissmann, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $1,564
Student in an Organized Health Care Education/Training Program $1,564
Lee Johnson, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $1,250
Student in an Organized Health Care Education/Training Program $1,250
Yun Wang
Student in an Organized Health Care Education/Training Program — Payments: $356.59
Student in an Organized Health Care Education/Training Program $356.59
Pardeep Khatri, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $323.55
Student in an Organized Health Care Education/Training Program $323.55